Can Ki-67 Play a Role in Prediction of Breast Cancer Patients' Response to Neoadjuvant Chemotherapy?

Background. Currently the choice of breast cancer therapy is based on prognostic factors. The proliferation marker Ki-67 is used increasingly to determine the method of therapy. The current study analyses the predictive value of Ki-67 in foreseeing breast cancer patients' responses to neoadjuva...

Descripción completa

Detalles Bibliográficos
Autores principales: Ingolf, Juhasz-Böss, Russalina, Mavrova, Simona, Moga, Julia, Radosa, Gilda, Schmidt, Bohle, Rainer M., Andrea, Hasenfus, Erich, Solomayer, Daniel, Herr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982412/
https://www.ncbi.nlm.nih.gov/pubmed/24783217
http://dx.doi.org/10.1155/2014/628217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982412/
https://www.ncbi.nlm.nih.gov/pubmed/24783217
http://dx.doi.org/10.1155/2014/628217

Ejemplares similares